FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4383501134> ?p ?o ?g. }

• W4383501134 endingPage "102158" @default.
• W4383501134 startingPage "102158" @default.
• W4383501134 abstract "One of the biggest factors that negatively affect the cancer treatment plan is the toxic effects of chemotherapeutics on non-target cells and tissues. This information prompted us to investigate the protective effects of silymarin (SL), a hepatoprotective agent, against the hepatotoxic effects of the anticancer drug paclitaxel (PAC). Four groups were formed from 28 rats as control, PAC (2 mg/kg), SL (100 mg/kg) and PAC + SL (combination of PAC with SL). After completing the experimental procedures, the tissues collected after anesthesia were analyzed by Western blot, qRT-PCR, biochemical, stereological, immunohistochemical, and histopathological techniques. Administration of PAC significantly increased the expression of tumor necrosis factor-alpha (TNF-α), Bax, cytochrome-c (cyt-c), and active caspase-3, as well as malondialdehyde (MDA) levels in liver tissue and decreased glutathione (GSH) levels compared with the control group. PAC also resulted in a significant increase in serum triglyceride (TG), cholesterol (CH), alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels compared with the control group. Pathological changes such as microvesicular steatosis, the formation of Councilman bodies, an increase in total sinusoidal volume, and a decrease in the total number of hepatocytes were observed in the liver tissue of the PAC group. Almost all analysis results in the PAC + SL group were similar to those in the control group, and no significant pathological alterations were observed in this group. The data obtained show that SL protects the liver from the harmful effects of PAC, especially thanks to its TNF-α suppressor, anti-inflammatory, anti-apoptotic and antioxidant effects. Based on this result, in cases where PAC is used in cancer treatment, it can be recommended to be used together with SL to prevent harmful effects on healthy liver tissue and to continue treatment uninterruptedly and effectively." @default.
• W4383501134 created "2023-07-08" @default.
• W4383501134 creator A5031658544 @default.
• W4383501134 creator A5035855838 @default.
• W4383501134 date "2023-08-01" @default.
• W4383501134 modified "2023-10-01" @default.
• W4383501134 title "Silymarin, an antioxidant flavonoid, protects the liver from the toxicity of the anticancer drug paclitaxel" @default.
• W4383501134 cites W1495549944 @default.
• W4383501134 cites W1628370182 @default.
• W4383501134 cites W1750163983 @default.
• W4383501134 cites W1775749144 @default.
• W4383501134 cites W1977528639 @default.
• W4383501134 cites W1980297252 @default.
• W4383501134 cites W1983310681 @default.
• W4383501134 cites W1989502324 @default.
• W4383501134 cites W1996522179 @default.
• W4383501134 cites W2003721688 @default.
• W4383501134 cites W2006370393 @default.
• W4383501134 cites W2006968024 @default.
• W4383501134 cites W2010395737 @default.
• W4383501134 cites W2021112085 @default.
• W4383501134 cites W2021568546 @default.
• W4383501134 cites W2022218465 @default.
• W4383501134 cites W2023341096 @default.
• W4383501134 cites W2025739711 @default.
• W4383501134 cites W2032703963 @default.
• W4383501134 cites W2036090034 @default.
• W4383501134 cites W2036660703 @default.
• W4383501134 cites W2046392949 @default.
• W4383501134 cites W2053054955 @default.
• W4383501134 cites W2059561866 @default.
• W4383501134 cites W2063392164 @default.
• W4383501134 cites W2069494381 @default.
• W4383501134 cites W2076708571 @default.
• W4383501134 cites W2111423100 @default.
• W4383501134 cites W2116404316 @default.
• W4383501134 cites W2116590803 @default.
• W4383501134 cites W2128473487 @default.
• W4383501134 cites W2134979684 @default.
• W4383501134 cites W2137303860 @default.
• W4383501134 cites W2140967934 @default.
• W4383501134 cites W2143176446 @default.
• W4383501134 cites W2147328441 @default.
• W4383501134 cites W2155772701 @default.
• W4383501134 cites W2157335302 @default.
• W4383501134 cites W2157786727 @default.
• W4383501134 cites W2163550320 @default.
• W4383501134 cites W2165101837 @default.
• W4383501134 cites W2186524545 @default.
• W4383501134 cites W2292921003 @default.
• W4383501134 cites W2314471280 @default.
• W4383501134 cites W2520145724 @default.
• W4383501134 cites W2563118732 @default.
• W4383501134 cites W2564380592 @default.
• W4383501134 cites W2752864716 @default.
• W4383501134 cites W2889099029 @default.
• W4383501134 cites W2905630510 @default.
• W4383501134 cites W2933377362 @default.
• W4383501134 cites W2969594661 @default.
• W4383501134 cites W2969644027 @default.
• W4383501134 cites W2987125724 @default.
• W4383501134 cites W2999024550 @default.
• W4383501134 cites W3008667926 @default.
• W4383501134 cites W3012542139 @default.
• W4383501134 cites W3021363784 @default.
• W4383501134 cites W3134433369 @default.
• W4383501134 cites W3152017727 @default.
• W4383501134 cites W3176541941 @default.
• W4383501134 cites W3186935765 @default.
• W4383501134 cites W3193132480 @default.
• W4383501134 cites W3196210561 @default.
• W4383501134 cites W3216764312 @default.
• W4383501134 cites W4205926830 @default.
• W4383501134 cites W4220793081 @default.
• W4383501134 cites W4225644760 @default.
• W4383501134 cites W4255762755 @default.
• W4383501134 cites W4284892919 @default.
• W4383501134 doi "https://doi.org/10.1016/j.tice.2023.102158" @default.
• W4383501134 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37459721" @default.
• W4383501134 hasPublicationYear "2023" @default.
• W4383501134 type Work @default.
• W4383501134 citedByCount "0" @default.
• W4383501134 crossrefType "journal-article" @default.
• W4383501134 hasAuthorship W4383501134A5031658544 @default.
• W4383501134 hasAuthorship W4383501134A5035855838 @default.
• W4383501134 hasConcept C121608353 @default.
• W4383501134 hasConcept C126322002 @default.
• W4383501134 hasConcept C134018914 @default.
• W4383501134 hasConcept C17991360 @default.
• W4383501134 hasConcept C181199279 @default.
• W4383501134 hasConcept C190283241 @default.
• W4383501134 hasConcept C202751555 @default.
• W4383501134 hasConcept C2776175330 @default.
• W4383501134 hasConcept C2776200302 @default.
• W4383501134 hasConcept C2776231280 @default.
• W4383501134 hasConcept C2777292972 @default.
• W4383501134 hasConcept C2778004101 @default.
• W4383501134 hasConcept C2778401633 @default.

• next